Medicare to partly cover extra cost of sepsis therapy, drug-eluting stents.
Thompson
Cheryl A
CA
D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000191:economics*; D013504:Cardiovascular Surgical Procedures / Q000009:adverse effects / Q000295:instrumentation; D023903:Coronary Restenosis / Q000517:prevention & control; D005251:Fees, Medical; D006761:Hospitals; D006801:Humans; D006278:Medicare / Q000191:economics*; D011486:Protein C / Q000008:administration & dosage / Q000191:economics*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000191:economics*; D012051:Reimbursement Mechanisms; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology; D015607:Stents / Q000191:economics*
D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated